Literature DB >> 12413307

The Kirschner operation in unresectable esophageal cancer: current application.

Brian P Whooley1, Simon Law, Sudish C Murthy, Andreas Alexandrou, Kent-Man Chu, John Wong.   

Abstract

HYPOTHESIS: With the introduction of safe, effective nonoperative alternatives, bypass surgery for unresectable esophageal cancer is infrequently performed, but it has a limited role in palliation of esophageal cancer that needs to be defined.
DESIGN: Retrospective cohort study.
SETTING: Department of Surgery at Queen Mary Hospital in Hong Kong. PATIENTS: Patients who had unresectable esophageal cancer and underwent bypass surgery between January 1, 1991, and December 31, 1998. INTERVENTION: Bypass procedures were performed using a gastric or colonic conduit to the neck. MAIN OUTCOME MEASURES: Morbidity and mortality and quality of palliation.
RESULTS: Thirty-eight patients underwent retrosternal bypass to the neck using a gastric (n = 27) or colonic (n = 11) conduit. Ten patients (26%) underwent unplanned bypass at the time of exploration for resection because of unexpected findings of T4 disease (n = 2) or technical difficulties in addition to advanced disease (n = 8). Between 1991 and 1994, 1 of 26 bypasses was unplanned and the hospital mortality was 42% (11/26), while between 1995 and 1998, 9 of 12 bypasses were unplanned and the hospital mortality was 8% (1/12). There were 12 hospital deaths in the planned bypass group (n = 28) and none in the unplanned bypass (n = 10) group (43% vs 0%, P =.01). The median survival in patients who underwent unplanned bypass was 6.9 months, compared with 1.9 months in patients who underwent planned bypass (P =.004). All patients were discharged from the hospital on at least a semisolid diet.
CONCLUSIONS: The Kirschner operation is largely obsolete as a planned procedure because of high morbidity and mortality. Bypass surgery, however, is a reasonable option as an unplanned procedure when resection is precluded at the time of exploration because of unexpected adverse operative findings.

Entities:  

Mesh:

Year:  2002        PMID: 12413307     DOI: 10.1001/archsurg.137.11.1228

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  5 in total

Review 1.  [Palliative bypass surgery].

Authors:  A Wojtyczka; T Moesta; C Kuntz; T Lehnert
Journal:  Chirurg       Date:  2006-03       Impact factor: 0.955

2.  Laparoscopic-assisted Esophageal Bypass for T4b Esophageal Tumor as a Bridge to Definitive Therapy.

Authors:  Spyridon Davakis; Athanasios Syllaios; Efstratia Mpaili; Theodoros Liakakos; Alexandros Charalabopoulos
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

Review 3.  Role of stenting in the palliation of gastroesophageal junction cancer: A brief review.

Authors:  Theodoros E Pavlidis; Efstathios T Pavlidis
Journal:  World J Gastrointest Surg       Date:  2014-03-27

4.  Laparoscopic retrosternal gastric pull-up for fistulized mediastinal mass.

Authors:  Benedetto Mungo; Arianna Barbetta; Anne O Lidor; Miloslawa Stem; Daniela Molena
Journal:  World J Gastrointest Surg       Date:  2017-03-27

5.  Bypass laparoscopic procedure for palliation of esophageal cancer.

Authors:  Marcos Duarte Siosaki; Croider Franco Lacerda; Paulo Anderson Bertulucci; José Orlando da Costa Filho; Antônio Talvane Torres de Oliveira
Journal:  J Surg Case Rep       Date:  2013-03-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.